false
OasisLMS
Catalog
Discussing the Emerging Role of hs-CRP in Clinical ...
Discussing the Emerging Role of hs-CRP in Clinical ...
Discussing the Emerging Role of hs-CRP in Clinical Practice
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The ACC webinar discusses the role of high-sensitivity C-reactive protein (HSCRP) in cardiovascular care, highlighting its importance in both primary and secondary prevention. Dr. Paul Ritker and Dr. Pyle Coley share insights about HSCRP as a biomarker for silent vascular inflammation, and its potential for predicting cardiovascular events, sometimes even more accurately than LDL cholesterol. They advocate for universal screening of HSCRP alongside LDL cholesterol and lipoprotein A for comprehensive risk assessment and personalized treatment. The discussion emphasizes that the presence of residual inflammatory risk, even when LDL levels are optimal, necessitates new strategies for intervention. Colchicine is currently FDA-approved to lower inflammation, but ongoing trials are exploring other anti-inflammatory agents like IL-6 inhibitors. The experts stress that lifestyle changes should be the first approach, with pharmacological interventions considered for persistent inflammation. The webinar concludes by stressing the need for healthcare providers to measure HSCRP routinely to address inflammation effectively in clinical practice, analogous to the standard practice of measuring LDL cholesterol and blood pressure.
Keywords
HSCRP
cardiovascular care
biomarker
inflammation
colchicine
IL-6 inhibitors
risk assessment
personalized treatment
×
Please select your language
1
English